Literature DB >> 6688001

Pharmacological action of breakdown products of atracurium and related substances.

D J Chapple, J S Clark.   

Abstract

The neuromuscular and cardiovascular effects of the breakdown products of atracurium and related substances have been studied in cats anaesthetized with chloralose. Laudanosine, the quaternary acid and metholaudanosine had no neuromuscular blocking activity within the dose range 0.5-4 mg kg-1. However, the quaternary monoacrylate, the quaternary alcohol and the monoquaternary analogue produced a dose-dependent neuromuscular block within this dose range. At 4 mg kg-1 mean arterial pressure was significantly reduced by 30-70 mm Hg following the administration of the quaternary monoacrylate, laudanosine, the quaternary alcohol, metholaudanosine and the monoquaternary analogue. At this dose only the monoquaternary analogue caused significant sympathetic blockade after preganglionic nerve stimulation. Significant vagal blockade occurred after 4 mg kg-1 of the quaternary monoacrylate, the quaternary acid, the quaternary alcohol and the monoquaternary analogue. In view of the low potencies of these substances, it is likely that the quantities present either as an impurity or likely to be formed after administration of therapeutic doses of atracurium (0.3-0.6 mg kg-1 i.v.) are of no pharmacological importance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6688001

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  Quantitative determination of atracurium in human plasma using high-performance liquid chromatography.

Authors:  R Okutani; K Kono; F M DeBros; D M Philbin
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

2.  Anaesthesia, atracurium and Duchenne muscular dystrophy.

Authors:  F A Rosewarne
Journal:  Can Anaesth Soc J       Date:  1986-03

Review 3.  Cisatracurium besilate. A review of its pharmacology and clinical potential in anaesthetic practice.

Authors:  H M Bryson; D Faulds
Journal:  Drugs       Date:  1997-05       Impact factor: 9.546

Review 4.  New intravenous anaesthetics and neuromuscular blocking drugs. A review of their properties and clinical use.

Authors:  C S Reilly; W S Nimmo
Journal:  Drugs       Date:  1987-07       Impact factor: 9.546

5.  Atracurium and severe hepatic disease: a case report.

Authors:  H K Gyasi; M Naguib
Journal:  Can Anaesth Soc J       Date:  1985-03

6.  Multiple electrocardiographic anomalies during anaesthesia in an athlete.

Authors:  M Abdulatif; M Fahkry; M Naguib; Y A Gyamfi; I Saeed
Journal:  Can J Anaesth       Date:  1987-05       Impact factor: 5.063

7.  Neuromuscular blockade with atracurium besylate in a patient with myasthenia gravis.

Authors:  D F Murphy; J B Magner
Journal:  Ir J Med Sci       Date:  1986-06       Impact factor: 1.568

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.